← All companies

ANL

Adlai Nortye Ltd.

ANL Nasdaq Pharmaceutical Preparations EDGAR ↗

$12.99

-0.01 -0.08%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.88 – $17.25

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K REPORT OF FOREIGN PRIVATE ISSUER Aug 3, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 17, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Apr 16, 2026 20-F ANNUAL REPORT Apr 10, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Apr 1, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Feb 12, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Feb 3, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 29, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 29, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 3, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Oct 22, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 9, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER May 30, 2025 20-F/A AMENDMENT NO. 1 TO FORM 20-F May 12, 2025 20-F ANNUAL REPORT Apr 30, 2025 20-F/A AMENDMENT NO. 1 TO FORM 20-F Feb 14, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Feb 14, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 31, 2024 6-K FORM 6-K Aug 8, 2024 6-K FORM 6-K Jul 3, 2024 6-K FORM 6-K Jun 27, 2024 6-K FORM 6-K May 24, 2024 20-F FORM 20-F Apr 19, 2024 6-K FORM 6-K Apr 2, 2024

Other filings

424B7 PROSPECTUS SUPPLEMENT Jul 20, 2026 3 Jul 15, 2026 4 PRIMARY DOCUMENT Jun 10, 2026 3 PRIMARY DOCUMENT Jun 1, 2026 3 PRIMARY DOCUMENT May 28, 2026 4 PRIMARY DOCUMENT May 21, 2026 3 PRIMARY DOCUMENT May 21, 2026 3 PRIMARY DOCUMENT May 20, 2026 SCHEDULE 13G May 15, 2026 SCHEDULE 13G/A May 14, 2026 3/A PRIMARY DOCUMENT May 14, 2026 3/A PRIMARY DOCUMENT May 8, 2026 3 PRIMARY DOCUMENT May 8, 2026 3 PRIMARY DOCUMENT Apr 29, 2026 EFFECT Apr 28, 2026 CORRESP Apr 24, 2026